Astrana Health Inc.
ASTH | NASDAQ
$33.55
-$0.81 (-2.36%)
At close: Sep 21, 2026, 4:00 PM ET
$33.95
+$0.40 (+1.18%)
Pre-market:
Sep 22, 2026, 5:57 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 3.18B | 2.03B | 1.39B | 1.14B | 773.92M | 370.25M |
Cost of Revenue | 2.89B | 1.76B | 1.17B | 944.69M | 596.14M | 348.54M |
Gross Profit | 295.78M | 271.39M | 214.96M | 199.48M | 177.77M | 21.71M |
Operating Income | 78.53M | 89.35M | 84.61M | 104.27M | 98.18M | 6.09M |
Interest Income | 12.16M | 14.51M | 14.21M | 1.98M | 1.57M | 405K |
Pretax Income | 39.61M | 80.82M | 89.84M | 86.62M | 77.75M | 8.87M |
Net Income | 22.49M | 43.15M | 60.72M | 45.17M | 68.92M | -23.75M |
Selling & General & Admin | 217.26M | 154.11M | 112.6M | 77.67M | 62.08M | 15.59M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | 27.93M | 17.75M | 17.54M | 17.52M | 26K |
Operating Expenses | 217.26M | 182.04M | 130.35M | 95.21M | 79.59M | 15.62M |
Interest Expense | 49.93M | 33.1M | 16.1M | 7.92M | 5.39M | 2.53M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.1B | 1.95B | 1.3B | 1.04B | 675.74M | 364.16M |
Income Tax Expense | 15.53M | 30.89M | 31.99M | 40.88M | 31.69M | 9.18M |
Shares Outstanding (Basic) | 49.08M | 47.69M | 46.71M | 44.97M | 43.83M | 36.53M |
Shares Outstanding (Diluted) | 49.37M | 48.22M | 47.07M | 45.6M | 45.4M | 37.45M |
EPS (Basic) | 0.46 | 0.91 | 1.30 | 1 | 1.57 | 1.04 |
EPS (Diluted) | 0.46 | 0.90 | 1.29 | 0.99 | 1.52 | 1.01 |
EBITDA | 135.28M | 141.84M | 123.69M | 112.08M | 100.66M | 29.74M |
EBIT | 89.53M | 113.92M | 105.94M | 94.54M | 83.14M | 11.39M |
Depreciation & Amortization | 45.75M | 27.93M | 17.75M | 17.54M | 17.52M | 18.35M |
Add to Watchlist
Select watchlists to add or remove ASTH